JP2011509290A - 抗癌剤としてのピラゾロ［３，４‐ｄ］ピリミジン誘導体 - Google Patents
抗癌剤としてのピラゾロ［３，４‐ｄ］ピリミジン誘導体 Download PDFInfo
- Publication number
- JP2011509290A JP2011509290A JP2010541891A JP2010541891A JP2011509290A JP 2011509290 A JP2011509290 A JP 2011509290A JP 2010541891 A JP2010541891 A JP 2010541891A JP 2010541891 A JP2010541891 A JP 2010541891A JP 2011509290 A JP2011509290 A JP 2011509290A
- Authority
- JP
- Japan
- Prior art keywords
- pyrazolo
- pyrimidin
- phenyl
- amine
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QUKPALAWEPMWOS-UHFFFAOYSA-N 1h-pyrazolo[3,4-d]pyrimidine Chemical class C1=NC=C2C=NNC2=N1 QUKPALAWEPMWOS-UHFFFAOYSA-N 0.000 title claims abstract 8
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 33
- 238000000034 method Methods 0.000 claims abstract 14
- 150000003839 salts Chemical class 0.000 claims abstract 6
- 230000001028 anti-proliverative effect Effects 0.000 claims abstract 5
- 238000004519 manufacturing process Methods 0.000 claims abstract 3
- 239000008194 pharmaceutical composition Chemical class 0.000 claims abstract 2
- -1 hydroxy, amino, hydroxyamino, carboxy, nitro, guanidino, ureido, carbamoyl Chemical group 0.000 claims 50
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 15
- 239000002904 solvent Substances 0.000 claims 13
- 239000000203 mixture Substances 0.000 claims 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 9
- 238000010992 reflux Methods 0.000 claims 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 8
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 8
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 6
- 239000002253 acid Substances 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 6
- 239000011707 mineral Substances 0.000 claims 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 6
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 6
- 229910052783 alkali metal Inorganic materials 0.000 claims 5
- 125000003282 alkyl amino group Chemical group 0.000 claims 5
- 239000002585 base Substances 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- 239000003586 protic polar solvent Substances 0.000 claims 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims 4
- OEICGMPRFOJHKO-UHFFFAOYSA-N 2-(ethoxymethylidene)propanedinitrile Chemical compound CCOC=C(C#N)C#N OEICGMPRFOJHKO-UHFFFAOYSA-N 0.000 claims 4
- MAKQREKUUHPPIS-UHFFFAOYSA-N 5-amino-1-phenyl-1H-pyrazole-4-carbonitrile Chemical compound NC1=C(C#N)C=NN1C1=CC=CC=C1 MAKQREKUUHPPIS-UHFFFAOYSA-N 0.000 claims 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 4
- 150000007513 acids Chemical class 0.000 claims 4
- 229910021529 ammonia Inorganic materials 0.000 claims 4
- 239000000010 aprotic solvent Substances 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims 4
- 238000006467 substitution reaction Methods 0.000 claims 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 3
- 239000001099 ammonium carbonate Substances 0.000 claims 3
- 235000012501 ammonium carbonate Nutrition 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 claims 3
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- SJBHYUWNPFYYNI-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-1-(3,5-dimethylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound CC1=CC(C)=CC(N2C3=NC=NC(NCC=4C=C5OCCOC5=CC=4)=C3C=N2)=C1 SJBHYUWNPFYYNI-UHFFFAOYSA-N 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 3
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- 239000012736 aqueous medium Substances 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 125000005605 benzo group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims 2
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 2
- 230000007062 hydrolysis Effects 0.000 claims 2
- 238000006460 hydrolysis reaction Methods 0.000 claims 2
- 150000004679 hydroxides Chemical class 0.000 claims 2
- 238000011065 in-situ storage Methods 0.000 claims 2
- 125000002346 iodo group Chemical group I* 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 claims 2
- 230000003472 neutralizing effect Effects 0.000 claims 2
- 125000002560 nitrile group Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 229940067157 phenylhydrazine Drugs 0.000 claims 2
- 150000004031 phenylhydrazines Chemical class 0.000 claims 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 claims 2
- 235000010288 sodium nitrite Nutrition 0.000 claims 2
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000005296 thioaryloxy group Chemical group 0.000 claims 2
- 125000005404 thioheteroaryloxy group Chemical group 0.000 claims 2
- 125000005270 trialkylamine group Chemical group 0.000 claims 2
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 claims 1
- HPARLNRMYDSBNO-UHFFFAOYSA-N 1,4-benzodioxine Chemical compound C1=CC=C2OC=COC2=C1 HPARLNRMYDSBNO-UHFFFAOYSA-N 0.000 claims 1
- YSWUDFATSBPVFL-UHFFFAOYSA-N 1-(3,5-dimethylphenyl)-n-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound COC1=C(OC)C(OC)=CC(CNC=2C=3C=NN(C=3N=CN=2)C=2C=C(C)C=C(C)C=2)=C1 YSWUDFATSBPVFL-UHFFFAOYSA-N 0.000 claims 1
- SQAKOPVOUSLGRS-UHFFFAOYSA-N 1-(3,5-dimethylphenyl)-n-[2-(2-methoxyethoxy)ethyl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound N1=CC=2C(NCCOCCOC)=NC=NC=2N1C1=CC(C)=CC(C)=C1 SQAKOPVOUSLGRS-UHFFFAOYSA-N 0.000 claims 1
- STYVEAOALAEULT-UHFFFAOYSA-N 1-(3-iodophenyl)pyrazolo[3,4-d]pyrimidine Chemical class IC1=CC=CC(N2C3=NC=NC=C3C=N2)=C1 STYVEAOALAEULT-UHFFFAOYSA-N 0.000 claims 1
- GETXGBDZZACJPV-UHFFFAOYSA-N 1-(3-methylphenyl)-n-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound COC1=C(OC)C(OC)=CC(CNC=2C=3C=NN(C=3N=CN=2)C=2C=C(C)C=CC=2)=C1 GETXGBDZZACJPV-UHFFFAOYSA-N 0.000 claims 1
- VLVZKHQSYVUBEA-UHFFFAOYSA-N 1-(3-methylphenyl)-n-[[4-(3-morpholin-4-ylpropoxy)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound CC1=CC=CC(N2C3=NC=NC(NCC=4C=CC(OCCCN5CCOCC5)=CC=4)=C3C=N2)=C1 VLVZKHQSYVUBEA-UHFFFAOYSA-N 0.000 claims 1
- GSILHXSZYLRDCW-UHFFFAOYSA-N 1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidine Chemical class CC1=CC=CC(N2C3=NC=NC=C3C=N2)=C1 GSILHXSZYLRDCW-UHFFFAOYSA-N 0.000 claims 1
- ROEFWOWUWFIFHP-UHFFFAOYSA-N 2-[[1-(3,5-dimethylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]acetic acid Chemical compound CC1=CC(C)=CC(N2C3=NC=NC(NCC(O)=O)=C3C=N2)=C1 ROEFWOWUWFIFHP-UHFFFAOYSA-N 0.000 claims 1
- DTTHGYPBDBANKG-UHFFFAOYSA-N 2-[[1-(3-cyanophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]acetic acid Chemical compound N1=CC=2C(NCC(=O)O)=NC=NC=2N1C1=CC=CC(C#N)=C1 DTTHGYPBDBANKG-UHFFFAOYSA-N 0.000 claims 1
- KDMNJOUCLAIXDH-UHFFFAOYSA-N 2-[[1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]acetic acid Chemical compound CC1=CC=CC(N2C3=NC=NC(NCC(O)=O)=C3C=N2)=C1 KDMNJOUCLAIXDH-UHFFFAOYSA-N 0.000 claims 1
- FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 claims 1
- PNAQLBVTHVBJOU-UHFFFAOYSA-N 3,5-dimethylpyrazolo[3,4-d]pyrimidine Chemical class N1=CN(C)C=C2C(C)=NN=C21 PNAQLBVTHVBJOU-UHFFFAOYSA-N 0.000 claims 1
- PNSVHQUIJWZNRG-UHFFFAOYSA-N 3-[4-[(3,4,5-trimethoxyphenyl)methylamino]pyrazolo[3,4-d]pyrimidin-1-yl]benzonitrile Chemical compound COC1=C(OC)C(OC)=CC(CNC=2C=3C=NN(C=3N=CN=2)C=2C=C(C=CC=2)C#N)=C1 PNSVHQUIJWZNRG-UHFFFAOYSA-N 0.000 claims 1
- BWEHNFAHJYUHNO-UHFFFAOYSA-N 3-[4-[(4-methoxyphenyl)methylamino]pyrazolo[3,4-d]pyrimidin-1-yl]benzonitrile Chemical compound C1=CC(OC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C#N)=C1 BWEHNFAHJYUHNO-UHFFFAOYSA-N 0.000 claims 1
- OXZQINWSJIVXFQ-UHFFFAOYSA-N 3-[4-[[3,4-bis(2-methoxyethoxy)phenyl]methylamino]pyrazolo[3,4-d]pyrimidin-1-yl]benzonitrile Chemical compound C1=C(OCCOC)C(OCCOC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C#N)=C1 OXZQINWSJIVXFQ-UHFFFAOYSA-N 0.000 claims 1
- OYZFRHPWEVEJQH-UHFFFAOYSA-N 3-[4-[[4-methoxy-3-(3-morpholin-4-ylpropoxy)phenyl]methylamino]pyrazolo[3,4-d]pyrimidin-1-yl]benzonitrile Chemical compound C1=C(OCCCN2CCOCC2)C(OC)=CC=C1CNC(C=1C=N2)=NC=NC=1N2C1=CC=CC(C#N)=C1 OYZFRHPWEVEJQH-UHFFFAOYSA-N 0.000 claims 1
- 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 claims 1
- WJHAGGMBBWXXCU-UHFFFAOYSA-N 3-pyrazolo[3,4-d]pyrimidin-1-ylbenzonitrile Chemical class N#CC1=CC=CC(N2C3=NC=NC=C3C=N2)=C1 WJHAGGMBBWXXCU-UHFFFAOYSA-N 0.000 claims 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims 1
- YMXQUFUYCADCFL-UHFFFAOYSA-N 4-chloro-1h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=NC=NC2=C1C=NN2 YMXQUFUYCADCFL-UHFFFAOYSA-N 0.000 claims 1
- UBKSUPKIDNXMMC-UHFFFAOYSA-N 5-amino-1-phenylpyrazole-4-carboxamide Chemical compound NC1=C(C(=O)N)C=NN1C1=CC=CC=C1 UBKSUPKIDNXMMC-UHFFFAOYSA-N 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- PARWGYPSBMSXSC-UHFFFAOYSA-N [4-(2-methoxyethoxy)phenyl]methanamine Chemical compound COCCOC1=CC=C(CN)C=C1 PARWGYPSBMSXSC-UHFFFAOYSA-N 0.000 claims 1
- 125000005236 alkanoylamino group Chemical group 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 150000003973 alkyl amines Chemical class 0.000 claims 1
- 125000003368 amide group Chemical group 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 150000003857 carboxamides Chemical class 0.000 claims 1
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 claims 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 208000026037 malignant tumor of neck Diseases 0.000 claims 1
- OHZZTXYKLXZFSZ-UHFFFAOYSA-I manganese(3+) 5,10,15-tris(1-methylpyridin-1-ium-4-yl)-20-(1-methylpyridin-4-ylidene)porphyrin-22-ide pentachloride Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mn+3].C1=CN(C)C=CC1=C1C(C=C2)=NC2=C(C=2C=C[N+](C)=CC=2)C([N-]2)=CC=C2C(C=2C=C[N+](C)=CC=2)=C(C=C2)N=C2C(C=2C=C[N+](C)=CC=2)=C2N=C1C=C2 OHZZTXYKLXZFSZ-UHFFFAOYSA-I 0.000 claims 1
- XERHTFBEABJMAL-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-1-(3,5-dimethylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound CC1=CC(C)=CC(N2C3=NC=NC(NCC=4C=C5OCOC5=CC=4)=C3C=N2)=C1 XERHTFBEABJMAL-UHFFFAOYSA-N 0.000 claims 1
- IIBPUCIUZPGZFD-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-1-(3-ethynylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C#CC1=CC=CC(N2C3=NC=NC(NCC=4C=C5OCOC5=CC=4)=C3C=N2)=C1 IIBPUCIUZPGZFD-UHFFFAOYSA-N 0.000 claims 1
- KEZHXUVPGGBABO-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound CC1=CC=CC(N2C3=NC=NC(NCC=4C=C5OCCOC5=CC=4)=C3C=N2)=C1 KEZHXUVPGGBABO-UHFFFAOYSA-N 0.000 claims 1
- JUIGKLFOQNJFIC-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-1-(3,5-dimethylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC(C)=CC(C)=C1 JUIGKLFOQNJFIC-UHFFFAOYSA-N 0.000 claims 1
- XYFNVSNOCNUOOR-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C)=C1 XYFNVSNOCNUOOR-UHFFFAOYSA-N 0.000 claims 1
- KSESLOVJGZDCDV-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=CC(OC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C)=C1 KSESLOVJGZDCDV-UHFFFAOYSA-N 0.000 claims 1
- UXLQRQRZMYFOJQ-UHFFFAOYSA-N n-[2-(2-methoxyethoxy)ethyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound N1=CC=2C(NCCOCCOC)=NC=NC=2N1C1=CC=CC(C)=C1 UXLQRQRZMYFOJQ-UHFFFAOYSA-N 0.000 claims 1
- QYFVWAXNXLJXPI-UHFFFAOYSA-N n-[[3,4-bis(2-methoxyethoxy)phenyl]methyl]-1-(3,5-dimethylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=C(OCCOC)C(OCCOC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC(C)=CC(C)=C1 QYFVWAXNXLJXPI-UHFFFAOYSA-N 0.000 claims 1
- DVQNZXMUTFGQDI-UHFFFAOYSA-N n-[[3,4-bis(2-methoxyethoxy)phenyl]methyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=C(OCCOC)C(OCCOC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C)=C1 DVQNZXMUTFGQDI-UHFFFAOYSA-N 0.000 claims 1
- UYWJCYDXLYIFMY-UHFFFAOYSA-N n-[[4-(2-methoxyethoxy)phenyl]methyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=CC(OCCOC)=CC=C1CNC1=NC=NC2=C1C=NN2C1=CC=CC(C)=C1 UYWJCYDXLYIFMY-UHFFFAOYSA-N 0.000 claims 1
- IJTBHPAXFRYDQY-UHFFFAOYSA-N n-[[4-methoxy-3-(3-morpholin-4-ylpropoxy)phenyl]methyl]-1-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=C(OCCCN2CCOCC2)C(OC)=CC=C1CNC(C=1C=N2)=NC=NC=1N2C1=CC=CC(C)=C1 IJTBHPAXFRYDQY-UHFFFAOYSA-N 0.000 claims 1
- PFIIOMYDQZYTJG-UHFFFAOYSA-N n-methyl-2,3-dihydro-1,4-benzodioxin-6-amine Chemical compound O1CCOC2=CC(NC)=CC=C21 PFIIOMYDQZYTJG-UHFFFAOYSA-N 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- JOVOSQBPPZZESK-UHFFFAOYSA-N phenylhydrazine hydrochloride Chemical class Cl.NNC1=CC=CC=C1 JOVOSQBPPZZESK-UHFFFAOYSA-N 0.000 claims 1
- 229940038531 phenylhydrazine hydrochloride Drugs 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N sulfur dioxide Inorganic materials O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 241000282412 Homo Species 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 0 CC(C)(*1CC1)C(C)(C)Nc1c(C=NC2C3=CC=CCC(C)(*)C3)c2ncn1 Chemical compound CC(C)(*1CC1)C(C)(C)Nc1c(C=NC2C3=CC=CCC(C)(*)C3)c2ncn1 0.000 description 11
- FUDYRLUSXBRPIA-UHFFFAOYSA-N NCc1ccc2OCCOc2c1 Chemical compound NCc1ccc2OCCOc2c1 FUDYRLUSXBRPIA-UHFFFAOYSA-N 0.000 description 2
- DCAGHONCMGBTFQ-UHFFFAOYSA-N C(c(cc1)cc2c1OCCO2)NC1=NC#CNc2c1cn[n]2-c1cccc(C2C=C2)c1 Chemical compound C(c(cc1)cc2c1OCCO2)NC1=NC#CNc2c1cn[n]2-c1cccc(C2C=C2)c1 DCAGHONCMGBTFQ-UHFFFAOYSA-N 0.000 description 1
- NWNCDLCLCUCLGM-UHFFFAOYSA-N CC(CC(C)=C1)C=C1[n]1ncc2c1NCN=C2I Chemical compound CC(CC(C)=C1)C=C1[n]1ncc2c1NCN=C2I NWNCDLCLCUCLGM-UHFFFAOYSA-N 0.000 description 1
- AEVYCCBBQXYEGQ-HSIYJIJGSA-N CC/C=C(/C)\C=C(/C#C)\N(c1ncnc(NCC(C2)C=CC3=C2OCCO3)c1C)[N]#C Chemical compound CC/C=C(/C)\C=C(/C#C)\N(c1ncnc(NCC(C2)C=CC3=C2OCCO3)c1C)[N]#C AEVYCCBBQXYEGQ-HSIYJIJGSA-N 0.000 description 1
- DWADKGUTZCUMBC-UHFFFAOYSA-N CCNc([n](-c1ccccc1)nc1)c1C#N Chemical compound CCNc([n](-c1ccccc1)nc1)c1C#N DWADKGUTZCUMBC-UHFFFAOYSA-N 0.000 description 1
- QOGNTTZQNNVGTI-BEKSENQBSA-N CS/C=C\C(\[n]1ncc2c1ncnc2O)=C/C=C/I Chemical compound CS/C=C\C(\[n]1ncc2c1ncnc2O)=C/C=C/I QOGNTTZQNNVGTI-BEKSENQBSA-N 0.000 description 1
- FVYNDWLGYVPQLZ-HAHHIUKWSA-N NC(c1c(N)[n](/C(/C=C\C=C\I)=C/C=N)nc1)=O Chemical compound NC(c1c(N)[n](/C(/C=C\C=C\I)=C/C=N)nc1)=O FVYNDWLGYVPQLZ-HAHHIUKWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN109CH2008 | 2008-01-11 | ||
| PCT/IN2009/000037 WO2009098715A2 (en) | 2008-01-11 | 2009-01-12 | Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011509290A true JP2011509290A (ja) | 2011-03-24 |
| JP2011509290A5 JP2011509290A5 (enExample) | 2012-10-25 |
Family
ID=40933862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010541891A Pending JP2011509290A (ja) | 2008-01-11 | 2009-01-12 | 抗癌剤としてのピラゾロ［３，４‐ｄ］ピリミジン誘導体 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8349847B2 (enExample) |
| EP (1) | EP2247596A2 (enExample) |
| JP (1) | JP2011509290A (enExample) |
| KR (1) | KR20100116607A (enExample) |
| CN (1) | CN101965350A (enExample) |
| AP (1) | AP2010005347A0 (enExample) |
| AU (1) | AU2009211004C1 (enExample) |
| BR (1) | BRPI0906475A2 (enExample) |
| CA (1) | CA2711777A1 (enExample) |
| CO (1) | CO6382174A2 (enExample) |
| EA (1) | EA201070841A1 (enExample) |
| GE (1) | GEP20135780B (enExample) |
| IL (1) | IL206811A0 (enExample) |
| MA (1) | MA32009B1 (enExample) |
| MX (1) | MX2010007523A (enExample) |
| NZ (1) | NZ586642A (enExample) |
| WO (1) | WO2009098715A2 (enExample) |
| ZA (1) | ZA201004823B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023508978A (ja) * | 2019-12-23 | 2023-03-06 | サンフォード バーナム プレビス メディカル ディスカバリー インスティテュート | エクトヌクレオチドピロホスファターゼ／ホスホジエステラーゼ１（ｅｎｐｐ１）モジュレーター及びその使用 |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2448938B9 (en) | 2009-06-29 | 2015-06-10 | Incyte Corporation | Pyrimidinones as pi3k inhibitors |
| WO2011075630A1 (en) * | 2009-12-18 | 2011-06-23 | Incyte Corporation | Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| WO2011075643A1 (en) * | 2009-12-18 | 2011-06-23 | Incyte Corporation | Substituted heteroaryl fused derivatives as pi3k inhibitors |
| EP2558463A1 (en) | 2010-04-14 | 2013-02-20 | Incyte Corporation | Fused derivatives as i3 inhibitors |
| US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
| JP5961187B2 (ja) | 2010-12-20 | 2016-08-02 | インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ | Ｐｉ３ｋ阻害剤としてのｎ−（１−（置換フェニル）エチル）−９ｈ−プリン−６−アミン |
| US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
| US9126948B2 (en) | 2011-03-25 | 2015-09-08 | Incyte Holdings Corporation | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors |
| MX389479B (es) | 2011-09-02 | 2025-03-20 | Incyte Holdings Corp | Heterociclilaminas como inhibidores de fosfoinositida 3-cinasas (pi3k) |
| AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
| CN102746307B (zh) * | 2012-07-09 | 2013-07-31 | 四川大学 | 1-n-苄基别嘌醇衍生物及其制备方法和用途 |
| CN102746309B (zh) * | 2012-07-09 | 2013-06-05 | 四川大学 | 1-N-乙基-4-N-2′-取代酰基肼-1H-吡唑[3,4-d]嘧啶类衍生物及其制备方法和用途 |
| CN103965202B (zh) * | 2014-05-21 | 2016-01-20 | 邹宏丽 | 二环稠合杂环化合物、其制备方法及用途 |
| US10077277B2 (en) | 2014-06-11 | 2018-09-18 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
| SG10201912302VA (en) | 2015-02-27 | 2020-02-27 | Incyte Corp | Salts of pi3k inhibitor and processes for their preparation |
| US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
| WO2016183060A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
| CN106008527B (zh) * | 2016-06-29 | 2018-05-15 | 四川大学华西医院 | 吡唑并[3,4-d]嘧啶衍生物 |
| CN107698596A (zh) * | 2017-11-15 | 2018-02-16 | 双鹤药业（商丘）有限责任公司 | 一种别嘌醇的合成方法 |
| IL278889B2 (en) | 2018-06-01 | 2025-11-01 | Incyte Corp | Dosing regimen for the treatment of pi3k related disorders |
| CN115304607B (zh) * | 2022-07-06 | 2023-06-27 | 华南农业大学 | 吡唑并嘧啶衍生物的制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3000688A (en) | 1961-09-19 | Process for vatting of vat dyestuffs | ||
| US3551428A (en) | 1956-02-10 | 1970-12-29 | Ciba Geigy Corp | New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines |
| JPS5439096A (en) | 1977-08-27 | 1979-03-24 | Lion Dentifrice Co Ltd | 11phenyll1hhpyrazolo*3*44d*pyrimidinee44 carbonitrile |
| US5877178A (en) | 1991-04-08 | 1999-03-02 | Duquesne University Of The Holy Ghost | Pyrimidine derivatives and methods of making and using these derivatives |
| US5958930A (en) | 1991-04-08 | 1999-09-28 | Duquesne University Of The Holy Ghost | Pyrrolo pyrimidine and furo pyrimidine derivatives |
| US5593997A (en) * | 1995-05-23 | 1997-01-14 | Pfizer Inc. | 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors |
| PL188959B1 (pl) | 1995-07-06 | 2005-05-31 | Novartis Ag | Pirolopirymidyny i sposoby ich wytwarzania |
| US6140317A (en) | 1996-01-23 | 2000-10-31 | Novartis Ag | Pyrrolopyrimidines and processes for their preparation |
| CH690773A5 (de) | 1996-02-01 | 2001-01-15 | Novartis Ag | Pyrrolo(2,3-d)pyrimide und ihre Verwendung. |
| US6537999B2 (en) | 1996-06-06 | 2003-03-25 | Duquesne University Of The Holy Ghost | Pyrimidine derivatives and methods of making and using these derivatives |
| PT938486E (pt) | 1996-08-23 | 2008-03-27 | Novartis Ag | Pirrolopirimidinas substituídas e processos para a sua preparação |
| DE19709488A1 (de) | 1997-03-07 | 1998-09-10 | Basf Ag | Verfahren zur N-Alkylierung von Aminen |
| WO1999007703A1 (en) | 1997-08-05 | 1999-02-18 | Pfizer Products Inc. | 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS |
| US6686366B1 (en) | 1998-06-02 | 2004-02-03 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| US6423871B1 (en) | 1999-02-26 | 2002-07-23 | University Of South Florida | Efficient synthesis of secondary amines by selective alkylation of primary amines |
| IL144977A0 (en) | 1999-05-21 | 2002-06-30 | Bristol Myers Squibb Co | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same |
| ITMI992711A1 (it) | 1999-12-27 | 2001-06-27 | Novartis Ag | Composti organici |
| AU2000240570A1 (en) | 2000-03-29 | 2001-10-08 | Knoll Gesellschaft Mit Beschraenkter Haftung | Pyrrolopyrimidines as tyrosine kinase inhibitors |
| BR0115847A (pt) | 2000-12-01 | 2004-02-25 | Osi Pharm Inc | Compostos especìficos para receptor para adenosina a1, a2a, e a3 e usos dos mesmos |
| US6680324B2 (en) | 2000-12-01 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
| US6673802B2 (en) | 2000-12-01 | 2004-01-06 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
| DE10060388A1 (de) | 2000-12-05 | 2002-06-06 | Merck Patent Gmbh | Verwendung von Pyrazolo [4,3-d]pyrimidinen |
| TWI238824B (en) | 2001-05-14 | 2005-09-01 | Novartis Ag | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives |
| WO2003000187A2 (en) | 2001-06-21 | 2003-01-03 | Ariad Pharmaceuticals, Inc. | Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof |
| GB0115393D0 (en) | 2001-06-23 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
| US7115617B2 (en) | 2001-08-22 | 2006-10-03 | Amgen Inc. | Amino-substituted pyrimidinyl derivatives and methods of use |
| US6939874B2 (en) | 2001-08-22 | 2005-09-06 | Amgen Inc. | Substituted pyrimidinyl derivatives and methods of use |
| ATE323702T1 (de) | 2002-08-06 | 2006-05-15 | Astrazeneca Ab | Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität |
| US20040138238A1 (en) | 2002-08-08 | 2004-07-15 | Dhanoa Dale S. | Substituted aminopyrimidine compounds as neurokinin antagonists |
-
2009
- 2009-01-12 KR KR1020107017777A patent/KR20100116607A/ko not_active Withdrawn
- 2009-01-12 GE GEAP200911914A patent/GEP20135780B/en unknown
- 2009-01-12 JP JP2010541891A patent/JP2011509290A/ja active Pending
- 2009-01-12 BR BRPI0906475-3A patent/BRPI0906475A2/pt not_active IP Right Cessation
- 2009-01-12 CN CN2009801083051A patent/CN101965350A/zh active Pending
- 2009-01-12 AP AP2010005347A patent/AP2010005347A0/en unknown
- 2009-01-12 CA CA2711777A patent/CA2711777A1/en not_active Abandoned
- 2009-01-12 EP EP09761144A patent/EP2247596A2/en not_active Withdrawn
- 2009-01-12 NZ NZ586642A patent/NZ586642A/en not_active IP Right Cessation
- 2009-01-12 US US12/812,405 patent/US8349847B2/en not_active Expired - Fee Related
- 2009-01-12 EA EA201070841A patent/EA201070841A1/ru unknown
- 2009-01-12 AU AU2009211004A patent/AU2009211004C1/en not_active Ceased
- 2009-01-12 WO PCT/IN2009/000037 patent/WO2009098715A2/en not_active Ceased
- 2009-01-12 MX MX2010007523A patent/MX2010007523A/es not_active Application Discontinuation
-
2010
- 2010-07-05 IL IL206811A patent/IL206811A0/en unknown
- 2010-07-08 ZA ZA2010/04823A patent/ZA201004823B/en unknown
- 2010-07-09 MA MA33007A patent/MA32009B1/fr unknown
- 2010-08-11 CO CO10098749A patent/CO6382174A2/es not_active Application Discontinuation
Non-Patent Citations (3)
| Title |
|---|
| JPN5011004969; ＣＡＶＡＳＯＴＴＯ Ｃ Ｎ: ＢＩＯＯＲＧＡＮＩＣ ＆ ＭＥＤＩＣＩＮＡＬ ＣＨＥＭＩＳＴＲＹ ＬＥＴＴＥＲＳ Ｖ１６ Ｎ７, 20060401, Ｐ１９６９-１９７４, ＰＥＲＧＡＭＯＮ， ＥＬＳＥＶＩＥＲ ＳＣＩＥＮＣＥ * |
| JPN7013002353; ＤＡＴＡＢＡＳＥ ＲＥＧＩＳＴＲＹ ［ＯＮＬＩＮＥ］ , 2006, ＣＨＥＭＩＣＡＬ ＡＢＳＴＲＡＣＴＳ ＳＥＲＶＩＣＥ * |
| JPN7013002354; ＤＡＴＡＢＡＳＥ ＲＥＧＩＳＴＲＹ ［ＯＮＬＩＮＥ］ , 2002, ＣＨＥＭＩＣＡＬ ＡＢＳＴＲＡＣＴＳ ＳＥＲＶＩＣＥ * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023508978A (ja) * | 2019-12-23 | 2023-03-06 | サンフォード バーナム プレビス メディカル ディスカバリー インスティテュート | エクトヌクレオチドピロホスファターゼ／ホスホジエステラーゼ１（ｅｎｐｐ１）モジュレーター及びその使用 |
| JP7794742B2 (ja) | 2019-12-23 | 2026-01-06 | サンフォード バーナム プレビス メディカル ディスカバリー インスティテュート | エクトヌクレオチドピロホスファターゼ／ホスホジエステラーゼ１（ｅｎｐｐ１）モジュレーター及びその使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009098715A2 (en) | 2009-08-13 |
| IL206811A0 (en) | 2010-12-30 |
| CA2711777A1 (en) | 2009-08-13 |
| AP2010005347A0 (en) | 2010-08-31 |
| AU2009211004B2 (en) | 2011-09-01 |
| NZ586642A (en) | 2012-04-27 |
| US8349847B2 (en) | 2013-01-08 |
| EP2247596A2 (en) | 2010-11-10 |
| MA32009B1 (fr) | 2011-01-03 |
| AU2009211004A2 (en) | 2011-01-27 |
| CN101965350A (zh) | 2011-02-02 |
| KR20100116607A (ko) | 2010-11-01 |
| US20100298351A1 (en) | 2010-11-25 |
| EA201070841A1 (ru) | 2011-02-28 |
| WO2009098715A3 (en) | 2009-10-15 |
| GEP20135780B (en) | 2013-03-11 |
| MX2010007523A (es) | 2010-08-18 |
| AU2009211004C1 (en) | 2013-08-01 |
| WO2009098715A4 (en) | 2009-12-10 |
| CO6382174A2 (es) | 2012-02-15 |
| AU2009211004A1 (en) | 2009-08-13 |
| ZA201004823B (en) | 2011-09-28 |
| BRPI0906475A2 (pt) | 2015-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8349847B2 (en) | Pyrazolo [3,4-D] pyrimidine derivatives as anti-cancer agents | |
| Kamath et al. | Targeting EGFR and HER‐2 receptor tyrosine kinases for cancer drug discovery and development | |
| CA2127411C (en) | Tricyclic derivatives | |
| US7250417B2 (en) | Arylmethyl triazolo- and imidazopyrazines as c-Met inhibitors | |
| JP4134227B2 (ja) | 縮合複素環化合物 | |
| KR101362621B1 (ko) | 화합물 | |
| TWI238824B (en) | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives | |
| US8507502B2 (en) | Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors | |
| US7037909B2 (en) | Tetracyclic compounds as c-Met inhibitors | |
| WO2008106635A1 (en) | Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors | |
| CZ20024223A3 (cs) | Deriváty 4-chinazolinaminů, způsob výroby a farmaceutický prostředek | |
| WO2008021859A1 (en) | Pyrrolotriazine kinase inhibitors | |
| RS20050441A (sr) | C-6 modifikovani indazolilpirolotriazini | |
| WO2013118817A1 (ja) | キノリルピロロピリミジン化合物又はその塩 | |
| US7151176B2 (en) | Pyrrolotriazine compounds | |
| JP2011502141A (ja) | 抗癌剤としての４‐（テトラゾール‐５‐イル）‐キナゾリン誘導体 | |
| JP2009533472A (ja) | 癌治療法 | |
| CN101657431A (zh) | 嘧啶-2，4-二胺衍生物及其作为jak2激酶抑制剂的用途 | |
| TW200524937A (en) | Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands | |
| TW201422610A (zh) | 作爲ｐｄｅ１０抑制劑之經二級醇取代之三唑 | |
| WO2021209039A1 (zh) | 一种喹唑啉类化合物、制备方法及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111214 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120904 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130624 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20131114 |